Programs

Scroll to explore

Scroll back top

GPCR target for metabolic diseases

23 February 2022

Precision Medicine and Immunotherapy of Sarcoma

A2aR/A2bR antagonist (M1069)

EP4 receptor antagonist (DT-9081)

Anti-CCR8 antibody (DT-7012)

9 February 2023

PAR2 antagonist (DT-9045)

26 February 2020

Undisclosed GPCR targets

mGluR4/7/8 PAM

NPFFR antagonist

22 November 2021

mGluR3 PAM